Abhilash Gadi

803 citations
17 papers · 574 indexed · h-index 13
Topics
Hippo pathway signaling and YAP/TAZ (4 papers)PI3K/AKT/mTOR signaling in cancer (3 papers)Cancer-related gene regulation (3 papers)

In The Last Decade

Abhilash Gadi

16 papers receiving 573 citations

Peers

Abhilash Gadi
Comparison fields: 5 of 86
  • Molecular Biology 376
  • Oncology 150
  • Cancer Research 140
  • Immunology 97
  • Cell Biology 61
Replace Saswati Karmakar with:
Saswati Karmakar United States
Shunlin Jiang United States
Shun‐Dong Dai China
Maria C. Cuitiño United States
Yusuke Suenaga Japan
Olubunmi Afonja United States
Melissa Hector-Greene United States
Volker Ellenrieder Germany
Jun‐ichi Suehiro Japan
Mariya Yakymovych Sweden
Abhilash Gadi relative to Saswati Karmakar United States Saswati Karmakar's profile →
Citations per field
00.5×1.5×
Saswati Karmakar · 1×
Citations per year

Countries citing papers authored by Abhilash Gadi

Since Specialization
Citations

This map shows the geographic impact of Abhilash Gadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abhilash Gadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abhilash Gadi more than expected).

Fields of papers citing papers by Abhilash Gadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abhilash Gadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abhilash Gadi. The network helps show where Abhilash Gadi may publish in the future.

Co-authorship network of co-authors of Abhilash Gadi

This figure shows the co-authorship network connecting the top 25 collaborators of Abhilash Gadi. A scholar is included among the top collaborators of Abhilash Gadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abhilash Gadi. Abhilash Gadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 4
2 26
3 8
4 12
5 0
6 27
7 24
8 122
9 75
10 73
11 19
12 38
13 14
14 1
15 42
16 36
17 53

About Abhilash Gadi

Abhilash Gadi is a scholar working on Cell Biology, Geriatrics and Gerontology and Rheumatology, having authored 17 papers that have together received 574 indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Cancer Research (140 citations), Oncology (150 citations) and Molecular Biology (376 citations). Abhilash Gadi has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Robert J. Schneider, Alka Mansukhani, Claudio Basilico, Giulia Maurizi, Narendra Verma, Shah Giashuddin, Rezina Arju, Beth Walters, Judy Zhong and Kenji Kato. Their work appears in journals such as Proceedings of the National Academy of Sciences, Genes & Development and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026